Proposed federal "Right to Try" legislation is superficially appealing, but the current version is too broad and risks undermining the imperative to conduct rigorous clinical studies to prove that a drug really works.
from Forbes Real Time https://www.forbes.com/sites/johnosborn/2017/10/07/right-to-try-unapproved-medicines-should-efficacy-be-optional/
via IFTTT
No comments:
Post a Comment